OPN-6602, a potent dual EP300/CBP bromodomain inhibitor, targets multiple myeloma through concomitant suppression of IRF4 and c-MYC
- AUTHORS Matusow, et al
- Programs OPN-6602
OPN-6602
OPN-6602, a dual EP300/CBP bromodomain inhibitor modulates androgen-driven transcription in mCRPC
- AUTHORS Matusow, et al
- Programs OPN-6602